Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Stem Cell Therapy for Tissue Regeneration01:21

Stem Cell Therapy for Tissue Regeneration

Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
Stem Cell Culture01:17

Stem Cell Culture

Stem cell research aims to find ways to use stem cells to regenerate and repair cellular damage. Over time, most adult cells undergo the wear and tear of aging and lose their ability to divide and repair themselves. Stem cells do not display a particular morphology or function. Adult stem cells, which exist as a small subset of cells in most tissues, keep dividing and can differentiate into a number of specialized cells generally formed by that tissue. These cells enable the body to renew and...
iPS Cell Differentiation01:22

iPS Cell Differentiation

The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Serial Coronary Artery Calcium Progression and Risk of Major Adverse Cardiovascular Events in an Asian Cohort.

Journal of clinical medicine·2026
Same author

Gut microbiome signatures discriminate deep vein thrombosis through machine learning and metabolic analysis.

Scientific reports·2026
Same author

Response to the Letter regarding "The additive impact of reduced symptom-to-door and door-to-balloon times on survival rates in acute ST-elevation myocardial infarction patients".

Journal of the Formosan Medical Association = Taiwan yi zhi·2026
Same author

Response to: Comment on 'comparative effectiveness of clopidogrel vs. potent P2Y12 inhibitors in CYP2C19 normal metabolizers following percutaneous coronary intervention: A real-world cohort study'.

British journal of clinical pharmacology·2026
Same author

Glycemic control and renal function decline in patients with chronic coronary syndrome: A multicenter cohort study.

Journal of diabetes investigation·2026
Same author

Transcriptomic Analysis of Adult Mouse Cardiac Stromal Cells Using Single-Cell qRT-PCR.

Cells·2026

Related Experiment Video

Updated: May 17, 2026

Delayed Intramyocardial Delivery of Stem Cells after Ischemia Reperfusion Injury in a Murine Model
07:50

Delayed Intramyocardial Delivery of Stem Cells after Ischemia Reperfusion Injury in a Murine Model

Published on: September 3, 2020

Stem cell-based therapy for ischemic heart disease.

Lien-Cheng Hsiao1, Carolyn Carr, Kuan-Cheng Chang

  • 1Cardiac Metabolism Research Group, Department of Physiology, Anatomy and Genetics, University of Oxford, Oxford, UK. lienchenghsiao@gmail.com

Cell Transplantation
|October 10, 2012
PubMed
Summary
This summary is machine-generated.

Stem cell therapy offers a promising new avenue for treating ischemic heart disease (IHD) and chronic heart failure (HF). Research explores various stem cell types and cardiac tissue engineering for cardiac repair and regeneration.

More Related Videos

Construction of Defined Human Engineered Cardiac Tissues to Study Mechanisms of Cardiac Cell Therapy
11:51

Construction of Defined Human Engineered Cardiac Tissues to Study Mechanisms of Cardiac Cell Therapy

Published on: March 1, 2016

Pluripotent Stem Cell Derived Cardiac Cells for Myocardial Repair
06:37

Pluripotent Stem Cell Derived Cardiac Cells for Myocardial Repair

Published on: February 3, 2017

Related Experiment Videos

Last Updated: May 17, 2026

Delayed Intramyocardial Delivery of Stem Cells after Ischemia Reperfusion Injury in a Murine Model
07:50

Delayed Intramyocardial Delivery of Stem Cells after Ischemia Reperfusion Injury in a Murine Model

Published on: September 3, 2020

Construction of Defined Human Engineered Cardiac Tissues to Study Mechanisms of Cardiac Cell Therapy
11:51

Construction of Defined Human Engineered Cardiac Tissues to Study Mechanisms of Cardiac Cell Therapy

Published on: March 1, 2016

Pluripotent Stem Cell Derived Cardiac Cells for Myocardial Repair
06:37

Pluripotent Stem Cell Derived Cardiac Cells for Myocardial Repair

Published on: February 3, 2017

Area of Science:

  • Regenerative Medicine
  • Cardiovascular Research
  • Stem Cell Biology

Background:

  • Ischemic heart disease (IHD) remains a leading cause of death globally, with chronic heart failure (HF) post-acute myocardial infarction (AMI) posing significant challenges.
  • Current treatments for end-stage HF, like heart transplantation, are limited by donor organ scarcity and the need for lifelong immunosuppression.
  • Stem cell-based cardiac therapy has emerged as a promising regenerative approach for IHD over the past decade.

Purpose of the Study:

  • To review the characteristics of various stem cell types applicable to cardiac repair.
  • To discuss stem cell-based therapeutic strategies for treating IHD.
  • To explore cardiac tissue engineering as an alternative to cell transplantation for improving cell retention and survival.

Main Methods:

  • Review of current literature on stem cell types (bone marrow cells, cardiac stem cells, induced pluripotent stem cells) for cardiac regeneration.
  • Analysis of stem cell-based therapy approaches, including direct cell transplantation and cardiac tissue engineering (CTE).
  • Discussion of the potential benefits and challenges associated with different stem cell sources and therapeutic modalities.

Main Results:

  • Multiple stem cell types, including bone marrow cells (BMCs), cardiac stem cells (CSCs), and induced pluripotent stem cells (iPSCs), show potential for cardiac repair.
  • Stem cell-based therapies, encompassing cell transplantation and cardiac tissue engineering (CTE), are being investigated to address limitations of current HF treatments.
  • CTE presents a potential solution to improve the engraftment and survival rates of transplanted cells in cardiac repair.

Conclusions:

  • Stem cell-based therapy represents a significant advancement in the potential treatment of ischemic heart disease and chronic heart failure.
  • Further research into stem cell characteristics and therapeutic strategies, including CTE, is crucial for clinical translation.
  • Developing effective stem cell therapies could offer a viable alternative to heart transplantation for patients with end-stage heart failure.